Cancer Inst. of New Jersey — New Brunswick, New Jersey

Cancer Inst. of New Jersey is a clinical research site located in New Brunswick, New Jersey, United States 08901.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Cancer Inst. of New Jersey has participated in 2 clinical trials.

Therapeutic areas: Carcinoma, Non-Squamous Non-Small Cell Lung, Breast Cancer.

Sponsors: Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Inst. of New Jersey?

Cancer Inst. of New Jersey has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Inst. of New Jersey conducted?

Cancer Inst. of New Jersey has 2 clinical trials on record. Their work covers Carcinoma, Non-Squamous Non-Small Cell Lung, Breast Cancer.

Is Cancer Inst. of New Jersey accredited by Crixeo Health?

Cancer Inst. of New Jersey has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer Inst. of New Jersey?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.